Gallion HH - Search Results

1

The efficacy of laser therapy in the treatment of cervical intraepithelial neoplasia.

Higgins RV, van Nagell JR Jr, Donaldson ES, Gallion HH, Pavlik EJ, Kryscio RJ. Higgins RV, et al. Among authors: gallion hh. Gynecol Oncol. 1990 Jan;36(1):79-81. doi: 10.1016/0090-8258(90)90112-x. Gynecol Oncol. 1990. PMID: 2295457

2

Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma.

Puls LE, Powell DE, DePriest PD, Gallion HH, Hunter JE, Kryscio RJ, van Nagell JR Jr. Puls LE, et al. Among authors: gallion hh. Gynecol Oncol. 1992 Oct;47(1):53-7. doi: 10.1016/0090-8258(92)90075-t. Gynecol Oncol. 1992. PMID: 1427402

3

Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women.

DePriest PD, Banks ER, Powell DE, van Nagell JR Jr, Gallion HH, Puls LE, Hunter JE, Kryscio RJ, Royalty MB. DePriest PD, et al. Among authors: gallion hh. Gynecol Oncol. 1992 Oct;47(1):71-5. doi: 10.1016/0090-8258(92)90079-x. Gynecol Oncol. 1992. PMID: 1427405

4

Molecular genetic changes in human epithelial ovarian malignancies.

Gallion HH, Powell DE, Morrow JK, Pieretti M, Case E, Turker MS, DePriest PD, Hunter JE, van Nagell JR Jr. Gallion HH, et al. Gynecol Oncol. 1992 Nov;47(2):137-42. doi: 10.1016/0090-8258(92)90096-2. Gynecol Oncol. 1992. PMID: 1468689

5

Phase II trial of amonafide in previously treated patients with advanced ovarian cancer: a Southwest Oncology Group study.

Gallion HH, Liu PY, Alberts DE, O'Toole RV, O'Sullivan J, Mills G, Smith HO, Hynes HE. Gallion HH, et al. Gynecol Oncol. 1992 Aug;46(2):230-2. doi: 10.1016/0090-8258(92)90261-g. Gynecol Oncol. 1992. PMID: 1500027 Clinical Trial.

6

Predictive value of specimen histology after preoperative radiotherapy in the treatment of bulky/barrel carcinoma of the cervix.

Maruyama Y, van Nagell JR, Powell D, Yoneda J, Donaldson E, Gallion HH, Kryscio RJ. Maruyama Y, et al. Among authors: gallion hh. Am J Clin Oncol. 1992 Apr;15(2):150-6. doi: 10.1097/00000421-199204000-00011. Am J Clin Oncol. 1992. PMID: 1553904

7

The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer.

Gallion HH, Hunter JE, van Nagell JR, Averette HE, Cain JM, Copeland LJ, Higgins RV, Husseinzadeh N, Nahhas WA, Partridge EE, et al. Gallion HH, et al. Gynecol Oncol. 1992 Jul;46(1):29-32. doi: 10.1016/0090-8258(92)90190-t. Gynecol Oncol. 1992. PMID: 1634137

8

Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.

Pavlik EJ, Nelson K, Srinivasan S, Powell DE, Kenady DE, DePriest PD, Gallion HH, van Nagell JR Jr. Pavlik EJ, et al. Among authors: gallion hh. Cancer Res. 1992 Aug 1;52(15):4106-12. Cancer Res. 1992. PMID: 1638522

9

Specimen findings and survival after preoperative 252Cf neutron brachytherapy for stage II cervical carcinoma.

Maruyama Y, Donaldson E, van Nagell JR, Yoneda J, Gallion HH, Powell D, Kryscio RJ. Maruyama Y, et al. Among authors: gallion hh. Gynecol Oncol. 1991 Dec;43(3):252-9. doi: 10.1016/0090-8258(91)90030-9. Gynecol Oncol. 1991. PMID: 1752495 Clinical Trial.

10

A review of californium-252 neutron brachytherapy for cervical cancer.

Maruyama Y, van Nagell JR, Yoneda J, Donaldson ES, Gallion HH, Powell D, Kryscio RJ. Maruyama Y, et al. Among authors: gallion hh. Cancer. 1991 Sep 15;68(6):1189-97. doi: 10.1002/1097-0142(19910915)68:6<1189::aid-cncr2820680602>3.0.co;2-f. Cancer. 1991. PMID: 1873769 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters